CARDIOPROGRESS
Foundation for the advancement of cardiology

Exploring Postinfarction Reentrant Ventricular Tachycardia With Entrainment Mapping Ventricular tachycardia late after myocardial infarction is usually due to reentry in the infarct region. These reentry circuits can be large, complex and difficult to define, impeding study in the electrophysiology laboratory and making catheter ablation difficult.

Appeals to “stay at home” during COVID-19 do not apply to heart attacks People experiencing heart attacks should immediately phone the emergency services – even during the COVID-19 pandemic. The urgent call from the European Society of Cardiology (ESC) comes as hospitals in Europe and beyond report dramatic reductions in heart attack admissions.

Vitamin K Antagonists and Osteoporotic Fractures: Insights From Comparisons With the NOACs Vitamin K antagonists (VKAs; warfarin mostly, but also acenocoumarol, phenprocoumon, phenindione, and fluindione) have been a cornerstone in medicine as the first and the only available oral anticoagulants (OACs) for clinical use for over half a century.

High haemoglobin A1c level is a possible risk factor for ventricular fibrillation in sudden cardiac arrest among non-diabetic individuals in the general population This study aimed to establish whether higher levels of glycated haemoglobin (HbA1c) are associated with increased sudden cardiac arrest (SCA) risk in non-diabetic individuals.

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The most distinctive comorbidities of 32 non-survivors from a group of 52 intensive care unit patients with novel coronavirus disease 2019 (COVID-19) in the study by Xiaobo Yang and colleagues were cerebrovascular diseases (22%) and diabetes (22%).

Mitral Regurgitation Management Focused Update: Key Points This is an update to the 2017 American College of Cardiology (ACC) expert consensus decision pathway (ECDP) on the management of mitral regurgitation (MR).

Europe to personalise prevention of second heart attacks Cardiovascular disease (CVD) is the top cause of death in Europe and worldwide, accounting for 47% of deaths in women and 39% of deaths in men.1 CVD costs the EU more than €210 billion a year,2 a sum expected to escalate with an ageing population and the cost of novel therapies.

Eating meat, including chicken, linked to heart disease risk in study Eating meat has been linked to heart disease in the latest study to suggest the food could pose some risk to our health.

Periodontitis increases the risk of suffering from future atherosclerotic cardiovascular disease It was already known, but so far there was no rigorous and exhaustive report that corroborated the link between periodontitis and the future risk of developing atherosclerotic cardiovascular disease. Now two of the international reference entities in the field of periodontal and cardiovascular health, the European Federation of Periodontics (VET) and the World Heart Federation (WHF), publish a consensus powerful that leaves no room for doubt.

PARTNER 2A Intermediate-Risk TAVR Five-Year Results Hit Print Late outcomes of transcatheter aortic valve replacement (TAVR) in the PARTNER 2A trial are now enshrined in the peer-reviewed literature.

AHA Flags Barriers to Women in Interventional Specialties A new scientific statement from the American Heart Association (AHA) addresses barriers to entry and retention of women in interventional vascular fields, including interventional cardiology, interventional radiology, and vascular surgery, and proposes potential solutions.

New Marker of Cardiovascular Risk Discovered in T2D A significant quantity of dysfunctional monocytes appears to indicate poor cardiovascular prognosis in patients with type 2 diabetes.

Don't Stop the Statin! Christopher P. Cannon Lipid lowering with statins is one of the most beneficial therapies in cardiovascular medicine, with evidence from hundreds of randomized clinical trials, including >25 large cardiovascular outcomes trials in the Cholesterol Treatment Trialists (CTT) collaboration.

Expert point of view Strategies to Overcome Residual Risk During Statins Era

PreHT 2020|Vilnius | Lithuania | 2-5 April 2020 7th International Conference on Prehypertension, Hypertension, Metabolic Disorders and Cardiovascular Disease (PreHT 2020)

Russian national congress of cardiology 2019

FDA Clears Architect Stat High-Sensitivity Troponin Test for MI The US Food and Drug Administration (FDA) has approved the Architect Stat (Abbott Laboratories) high-sensitivity troponin-I assay, which can detect myocardial infarction (MI) faster and more accurately than other troponin tests, according to the company.

World Heart Day 2019 This year on World Heart Day, as part of our mission to ensure heart health equity for all, we want to create a global community of Heart Heroes … people from all walks of life who are acting now to live longer, better, heart-healthy lives by making a promise: for MY HEART, for YOUR HEART, for ALL OUR HEARTS.

ESC 2019: Wrap up in Russian - Live and interactive programme In collaboration with the Russian Society of Cardiology, this programme is designed to present a selection of scientific highlights from ESC Congress and discuss clinical practice implications with experts.

ESC Congress 2019 together with World Congress of Cardiology ESC Congress 2019 together with World Congress of Cardiology Saturday 31 August - Wednesday 4 September 2019 Paris - France